Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation

被引：26
|
作者：
Morikawa, Mamoru [1 ]
Yamada, Takashi [1 ]
Yamada, Hideto [1 ]
Minakami, Hisanori [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608638, Japan
来源：
OBSTETRICS AND GYNECOLOGY | 2006年 / 108卷 / 03期
关键词：
D O I：
10.1097/01.AOG.0000191584.28717.2c
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
BACKGROUND: The effect of gonadotropin-releasing hormone agonist (GnRHa) on uterine arteriovenous malformations (AVM) is not well known. CASE: A 37-year-old woman with a previous cesarean was diagnosed as having a uterine AVM after a spontaneous abortion with massive vaginal bleeding. The AVM decreased in size from 5.1 x 3.8 cm to 1.4 x 1.0 cm after 6 months of therapy with a GnRHa. Uterine artery embolization conducted after the GnRH therapy resulted in complete disappearance of the AVM. The patient's menstrual cycles and ovulation resumed 3 months after uterine artery embolization. CONCLUSION: Gonadotropin-releasing hormone agonist therapy reduced the size of the uterine AVM. Thus, GnRHa therapy may be useful for uterine AVM in situations where uterine artery embolization must be postponed.
引用
收藏
页码：751 / 753
页数：3
相关论文
共 50 条
  • [21] EFFECT OF CHRONIC GONADOTROPIN-RELEASING HORMONE AGONIST THERAPY ON TESTICULAR STEROIDOGENESIS
    RAJFER, J
    SWERDLOFF, RS
    XIE, HW
    SIKKA, SC
    FERTILITY AND STERILITY, 1984, 42 (02) : 325 - 325
  • [22] THE EFFECT OF A GONADOTROPIN-RELEASING HORMONE AGONIST ANALOG (NAFARELIN) ON BONE METABOLISM
    JOHANSEN, JS
    RIIS, BJ
    HASSAGER, C
    MOEN, M
    JACOBSON, J
    CHRISTIANSEN, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (04): : 701 - 706
  • [23] Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex
    Wiwanitkit, Viroj
    SEXUALITY AND DISABILITY, 2006, 24 (03) : 175 - 178
  • [24] Mathematical Model for Gonadotropin Secretion under the Effect of Gonadotropin-Releasing Hormone and Gonadotropin-Releasing Hormone Receptor
    Viroj Wiwanitkit
    Sexuality and Disability, 2007, 25 : 41 - 43
  • [25] Mathematical model for gonadotropin secretion under the effect of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor
    Wiwanitkit, Viroj
    SEXUALITY AND DISABILITY, 2007, 25 (01) : 41 - 43
  • [26] Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex
    Viroj Wiwanitkit
    Sexuality and Disability, 2006, 24 : 175 - 178
  • [27] Therapeutic effect and underlying mechanism of Gonadotropin-releasing hormone in uterine fibroids
    Gong, Y. F.
    Han, W.
    Cui, Y.
    Li, L. Y.
    Lu, L. Y.
    Ren, C. N.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (04): : 1437 - 1443
  • [28] Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls
    Arani, Kobra Shiasi
    Heidari, Fatemeh
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 13 (03)
  • [29] INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENT
    BERGQUIST, C
    NILLIUS, SJ
    WIDE, L
    LANCET, 1979, 2 (8136): : 215 - 217
  • [30] GONADOTROPIN-RELEASING HORMONE AGONIST TREATMENT OF ENDOMETRIOSIS AND MYOMAS
    GIUDICE, LC
    WESTERN JOURNAL OF MEDICINE, 1990, 152 (04): : 409 - 409
12345